Escalation Adjustment Airframe and Optional Features Agreement (Supplemental Exhibit AE1 to Purchase Agreement No. 3219) between The Boeing Company and American Airlines, Inc.

Summary

This agreement is a supplemental exhibit to a purchase agreement between The Boeing Company and American Airlines, Inc. It outlines the formula and procedures for adjusting the price of airframes and optional features based on escalation factors. The document specifies how values will be determined if certain data becomes unavailable. Key terms and formulas are confidential and have been omitted from the public version. The agreement ensures both parties have a clear method for price adjustments over time.

EX-10.138D 26 ex10138d.htm PURCHASE AGREEMENT NO. 3219 ex10138d.htm
 
 

 

ESCALATION ADJUSTMENT


AIRFRAME AND OPTIONAL FEATURES


between

THE BOEING COMPANY

and

AMERICAN AIRLINES, INC.


Supplemental Exhibit AE1 to Purchase Agreement Number 3219


P.A. No. 3219                                                              AE1
PA_Supp_EX_AE1_ECI-W_2006   Rev.: 2/18/08
BOEING PROPRIETARY



 
 

 


1.           Formula.

[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]







































[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]































 
Note:
i.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
ii.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
iii.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
iv.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
v.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
vi.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

2.           Values to be Utilized in the Event of Unavailability.

2.1           [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

2.2           [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

2.3                  [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

2.4           [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
Note:
i.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

 
ii.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]

P.A. No. 3219                                                          AE1-
PA_Supp_EX_AE1_ECI-W_2006   Rev.: 2/18/08
BOEING PROPRIETARY